先看重點
這項納入46項研究的系統綜述發現,加速度計和陀螺儀檢測呼吸暫停及低通氣事件的敏感性為30%至99%,表現最好的多是受控條件下的模擬研究。僅少數研究以多導睡眠監測為參照或納入有臨床代表性的患者,且偏倚風險較高。
證據類型
證據回顧
解讀依據
公開摘要
閱讀重點
方法與適用範圍
研究在問什麼
多導睡眠監測是診斷睡眠呼吸暫停的標準,但費用高、操作複雜、難以獲得,限制了大規模篩查和長期監測。研究者想知道,加速度計和陀螺儀等運動感測器檢測呼吸暫停和低通氣事件的效果如何,證據是否足以用於臨床。
研究對象與方法
按PRISMA 2020規範進行系統綜述,於2025年4月12日檢索PubMed、Embase、Scopus、Web of Science和IEEE Xplore。納入使用加速度計、陀螺儀、慣性測量單元、心震圖或心衝擊圖檢測呼吸暫停或低通氣的研究。提取感測器配置、訊號處理、驗證策略、診斷表現和臨床適用性,並用QUADAS-2工具(診斷準確性研究質量評價工具第2版)評價研究質量。
主要發現
以下為作者報告的結果。數值須連同族群和不確定性一起閱讀。
- 1共納入2010年至2025年發表的46項研究。多數以加速度計為主要感測器,陀螺儀主要用於多模態慣性測量單元系統。
- 2常見做法是對呼吸暫停期與非暫停期做二分類。報告的敏感性為30%至99%,取決於研究場景、驗證策略和評價層級。
- 3高表現主要見於受控條件下的模擬研究。各研究在感測器位置、取樣頻率、預處理、分段方法、驗證方式和參照標準上差異很大。
- 4僅少數研究以多導睡眠監測為參照標準或納入有臨床代表性的族群。外部驗證有限、可重複性不足以及偏倚風險高,降低了結果的可比性和臨床適用性。
限制與不確定性
- 1各研究在感測器、佩戴位置和驗證方法上差異太大,無法合併,因此30%至99%的敏感性範圍不能概括為一個準確度數字。
- 2不少研究依賴模擬的呼吸暫停或受控環境,可能高估真實患者在家睡眠時的表現。
- 3外部驗證和有臨床代表性的受試者很少,綜述發現偏倚風險較高。本解讀僅基於摘要。
日常健康啟示
基於運動感測器的睡眠呼吸暫停篩查在穿戴式和居家監測場景中有前景,但尚未證明可靠到足以替代睡眠監測。消費級裝置不能告訴你是否患有睡眠呼吸暫停。如果你打鼾嚴重、夜間有憋氣或醒後仍覺疲憊,請向醫師諮詢規範檢查。
如何連結自己的資料
能估計睡眠中呼吸或體動的穿戴式裝置和床旁感測器是最接近的消費級對應物,但其數值只是篩查線索,不是診斷。請用同一裝置觀察數週的規律,持續的擔憂應交給醫師評估。
如何理解這類證據
先看納入了哪些設計、文獻搜尋與偏誤評估如何完成,以及搜尋截止日期;發表新不代表底層證據都是最新的。
作者的結構化摘要 English
以下英文摘要依所記錄的開放授權轉載,屬於作者原始材料,並非 MoveVitals 解讀。上方已提供研究解讀,分別說明作者結果與本站解釋;重要結論可直接查核原文。
Background
Sleep apnea is a common but frequently underdiagnosed disorder associated with increased cardiovascular and metabolic risk. Although polysomnography remains the diagnostic gold standard, its high cost, technical complexity, and limited availability restrict large-scale screening and continuous monitoring. Accelerometry-based and gyroscope-based approaches may represent a simplified alternative that can also be applied in home-based settings.
Objective
This systematic review aimed to evaluate the technical and clinical evidence for accelerometry-based and gyroscope-based detection of apnea and hypopnea events and to assess their potential clinical applicability.
Methods
A systematic literature search was conducted on April 12, 2025, in PubMed, Embase, Scopus, Web of Science, and IEEE Xplore following PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 guidelines. Studies investigating accelerometers, gyroscopes, inertial measurement units, seismocardiography, or ballistocardiography for apnea or hypopnea detection were included. Extracted data comprised study characteristics, sensor configurations, signal processing approaches, validation strategies, diagnostic performance, and clinical applicability. Methodological quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool.
Results
A total of 46 studies published between 2010 and 2025 were included. Most studies used accelerometers as the primary sensing modality, whereas gyroscopes were mainly applied in multimodal inertial measurement unit systems. Binary classification between apnea and nonapnea phases was the predominant analytical approach. Reported sensitivities ranged from 30% to 99%, depending on study settings, validation strategies, and evaluation levels. High diagnostic performance was mainly observed in simulation-based studies under controlled conditions. The included studies differed considerably in sensor placement, sampling frequencies, preprocessing pipelines, segmentation strategies, validation procedures, and reference standards. Only a minority of studies used polysomnography as the reference standard or included clinically representative populations. Furthermore, limited external validation, insufficient reproducibility, and a high risk of bias reduced comparability and clinical transferability.
Conclusions
Current evidence supports the feasibility of accelerometer-based respiratory monitoring for sleep apnea screening, particularly in wearable and home-monitoring settings. However, most available studies were conducted under controlled experimental conditions and included only limited clinical validation. Standardized validation procedures and clinically representative cohorts are necessary to improve comparability and clinical transferability.
來源與署名
Accelerometry-Based and Gyroscope-Based Detection of Sleep Apnea Events: Systematic Review of Technical and Clinical Evidence.
Werle R, Kuhlmann R, Albrecht UV.
JMIR biomedical engineering · 2026-10-22
DOI: 10.2196/104899 ↗PubMed · 42954060 ↗Europe PMC · 所記錄的開放授權: cc by ↗摘要著作權歸原作者,依來源紀錄的開放授權轉載。中文譯文協助閱讀,英文摘要供查核術語及具體數值;本站的方法學解釋與作者結論分別呈現。
MoveVitals 編輯解讀 · 健康教育內容 · 未記錄個人臨床審閱
來源查核日期 2026-11-01
實用健康指南
放在一起讀
運動改善45歲及以上睡眠障礙者的睡眠質量評分
彙總23項隨機對照試驗、共1,478名45至77歲睡眠障礙成年人的資料,運動改善了匹茲堡睡眠質量指數評分(SMD 0.62,95%置信區間0.40–0.83),網路分析中有氧運動效果最大(SMD 1.34,95%可信區間0.86–1.82)。證據確定性為低到中等,結局是問卷評分,每週約539 MET-min的最佳劑量是模型估計值,不是處方。
Journal of Exercise Science & Fitness
睡眠規律性比睡眠時長更能預測英國成年人的死亡風險
在60,977名佩戴腕式加速度計一週的英國生物樣本庫成年人中,睡眠最規律的五分之一族群,經完全校正後的全因死亡風險比為0.70(95%置信區間0.59–0.83),對照為最不規律的五分之一,追蹤約6.3年,共1859人死亡。規律性對資料的擬合優於睡眠時長,但這是隻依據一週資料的觀察性研究。
Sleep
延長睡眠使超重成年人每日能量攝取減少約270千卡
在80名平時睡眠不足6.5小時的超重成年人中,兩週的延長睡眠指導使睡眠增加約1.2小時,實測能量攝取比對照組少270.4千卡/天(95%置信區間−393.4至−147.4)。這是一項為期短、單中心、族群較窄的試驗,不能說明體重會持續下降,也不能說明對睡眠本就充足的人有益。
JAMA Internal Medicine
50歲和60歲時每晚睡6小時及以下,與日後失智風險較高相關
在7959名英國公務員中追蹤約25年,50歲時每晚睡6小時及以下者的失智風險比為1.22(95%置信區間1.01–1.48),60歲時為1.37(1.10–1.72),均高於睡7小時者;長期持續睡眠偏短者為1.30(1.00–1.69)。睡眠主要靠自報,且為觀察性研究,早期腦部病變等因素可能解釋了部分關聯。
Nature Communications

